March 22, 2022
by Andrii Buvailo
Interview
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Aug. 15, 2022
by Andrii Buvailo
Interview
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
July 8, 2020
by Andrii Buvailo
Biopharma insight
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- …
April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
Jan. 19, 2022
by Alan Nafiiev
Biopharma insight
Over the last five or so years, the drug discovery industry has started adopting artificial intelligence (AI) at unprecedented scale, …
July 21, 2016
by Andrii Buvailo
Biopharma insight
Drug repositioning is a smart and cost-effective approach used by some pharmaceutical companies to re-invent their previously successful drugs in …
April 27, 2020
by Andrii Buvailo
Interview
Generative models have become one of the hottest areas in de-novo molecular design over just several years, basically revolutionizing our …
Jan. 22, 2021
by Andrii Buvailo
Interview
With several decades of advances in quantum theory and simultaneous progress in a number of software and hardware fields, we …
Feb. 4, 2022
by Alan Nafiiev
Biopharma insight
The BRD4 (Bromodomain-containing protein 4) protein is a transcriptional factor that plays an important role in cancer development. It has …
May 12, 2020
by Andrii Buvailo
Interview
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …
July 12, 2022
by Natalia Honchar
News
Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …
Jan. 21, 2019
by Andrii Buvailo
Biopharma insight
The first month of 2019 is not over yet, but there are already four major announcements about new research projects …